Clinical Trial News and Research

RSS

Wake Forest researchers to study bone health post-bariatric surgery with $1.5 million NIH grant

Researchers at Wake Forest University of School of Medicine have received a five-year, $1.5 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, to study bone microarchitecture in patients following bariatric surgery.

30 May 2024

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

Many countries with national healthcare systems or payers such as insurance companies use cost-effectiveness analyses to decide whether to cover new medicines, balancing treatment costs with potential health benefits.

30 May 2024

Early peanut consumption slashes allergy risk by 71%, landmark study finds

A recent study published in NEJM Evidence found that feeding children peanut products regularly from infancy to age five reduced the rate of peanut allergy in adolescence by 71%, providing long-term prevention through early allergen consumption

29 May 2024

New type of immunotherapy shows promising preclinical results against osteosarcoma

A new type of immunotherapy, developed by UCL researchers, has shown promising preclinical results against a bone cancer called osteosarcoma, as part of a study in mice.

29 May 2024

RNA-based therapy shows promise in reducing cholesterol and triglycerides

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.

29 May 2024

Vaccination remains crucial for preventing avian influenza spread, says study

Vaccination remains the most effective strategy for avian influenza prevention and control in humans, despite varying vaccine efficacy across strains.

29 May 2024

Study finds kidney complications following heart failure hospitalization

In a study of Medicare beneficiaries, researchers from Brigham and Women's Hospital found that one year after hospitalization for heart failure, 6 percent of patients had progressed to dialysis.

29 May 2024

Psychoactive drugs are having a moment. The FDA will soon weigh in.

Lori Tipton is among the growing number of people who say that MDMA, also known as ecstasy, saved their lives.

29 May 2024

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

A recent study in Nature Medicine found that LM11A-31, targeting the p75 neurotrophin receptor, is safe and shows promise in slowing Alzheimer's disease progression. The trial indicated significant biomarker improvements and potential benefits for further clinical investigation.

28 May 2024

Study highlights a dietary strategy for health improvement and weight management

A new study by researchers from Arizona State University and their colleagues highlights a dietary strategy for significant health improvement and weight management.

28 May 2024

New paper reveals the broad potential of TNIK as a therapeutic target for some aging-related diseases

A new paper in Trends in Pharmacological Sciences from researchers at generative artificial intelligence (AI)- and robotics-powered clinical stage drug discovery company Insilico Medicine ("Insilico") and ETH Zurich reveals the broad potential of TNIK as a therapeutic target for some of the most pervasive aging-related diseases, including fibrosis, cancer, obesity, and Alzheimer's.

28 May 2024

Automated text reminders boost mental health for health care workers

Health care workers have reported spikes in feeling burnt out in the time since the COVID-19 pandemic began, with nearly half saying it took a toll in 2022 compared to 32 percent in 2018.

28 May 2024

Exonate appoints Dr Rafiq Hasan as Non-Executive Director

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced the expansion of its Board with the appointment of Dr Rafiq Hasan as Non-Executive Director. Rafiq brings extensive expertise in ophthalmology, specifically within the diabetic eye disease sector, from his years in global pharmaceutical businesses.

28 May 2024

Early peanut introduction reduces allergy risk by 71% in adolescents

Feeding children peanuts regularly from infancy to age five reduced the rate of peanut allergy in adolescence by 71%, even after many years when the children ate or avoided peanut as desired.

27 May 2024

$Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy$

Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy

A research team at Osaka University will start an investigator-initiated clinical trial for refractory prostate cancer patients after the successful development of a new alpha-ray therapeutic agent ([At-211] PSMA-5) and confirmation of its efficacy in animal models.

27 May 2024

AI-based body composition analysis predicts lung cancer treatment outcomes

1
2
3
4
...
1059
Next

Clinical Trial News and Research

Wake Forest researchers to study bone health post-bariatric surgery with $1.5 million NIH grant

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

Early peanut consumption slashes allergy risk by 71%, landmark study finds

New type of immunotherapy shows promising preclinical results against osteosarcoma

RNA-based therapy shows promise in reducing cholesterol and triglycerides

Vaccination remains crucial for preventing avian influenza spread, says study

Study finds kidney complications following heart failure hospitalization

Psychoactive drugs are having a moment. The FDA will soon weigh in.

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

Study highlights a dietary strategy for health improvement and weight management

New paper reveals the broad potential of TNIK as a therapeutic target for some aging-related diseases

Automated text reminders boost mental health for health care workers

Exonate appoints Dr Rafiq Hasan as Non-Executive Director

Early peanut introduction reduces allergy risk by 71% in adolescents

Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy

AI-based body composition analysis predicts lung cancer treatment outcomes

Phase 1 trial for EBC-129 progresses into dose expansion

Study finds no significant survival benefit from participating in cancer clinical trials

Insilico Medicine's leadership to address key challenges in AI drug discovery at BIO Convention

New study advocates for de-escalating breast cancer surgery in women aged 55 and older

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News